Do we need a patient-centered target for systolic blood pressure in hypertensive patients with type 2 diabetes mellitus?

Hypertension

Volumn 70, Issue 6, 2017, Pages 1273-1282

  Wan, Eric Yuk Fai ^a   Yu, Esther Yee Tak ^a   Fung, Colman Siu Cheung ^a   Chin, Weng Yee ^a   Fong, Daniel Yee Tak ^a   Chan, Anca Ka Chun ^a   Lam, Cindy Lo Kuen ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Blood pressure; Cardiovascular diseases; Diabetes mellitus; Hypertension; Mortality

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CAUSE OF DEATH; CLINICAL TRIAL; COMPLICATION; DISEASE MANAGEMENT; HONG KONG; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SYSTOLE; TIME FACTOR; TRENDS;

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SYSTOLE; TIME FACTORS;

EID: 85037681124     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.10034     Document Type: Article

References (47)

1. International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104:1-52. doi: 10.1016/j.diabres.2012.10.001.
2. Food and Health Bureau HKSAR. Hong Kong reference framework for diabetes care for adults in primary care settings. First published 2010. Revised edition 2017. http://www.pco.gov.hk/english/resource/files/e-diabetes-care.pdf. Accessed October 2, 2017.
3. Dasgupta K, Quinn RR, Zarnke KB, et al; Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014;30:485-501. doi: 10.1016/j.cjca.2014.02.002.
4. American Diabetes Association. Standards of medical care in diabetes - 2015: summary of revisions. Diabetes Care. 2015;38:S70-S76. doi: 10.2337/dc15-S003.
5. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
6. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14-26. doi: 10.1111/jch.12237.
7. Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, Sanchez E. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63:1230-1238. doi: 10.1016/j.jacc.2013.11.007.
8. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011;343:d6898.
9. McBrien K, Rabi DM, Campbell N, Barnieh L, Clement F, Hemmelgarn BR, Tonelli M, Leiter LA, Klarenbach SW, Manns BJ. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2012;172:1296-1303. doi: 10.1001/archinternmed.2012.3147.
10. Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation. 2011;123:2799-2810, 9 p following 810. doi: 10.1161/CIRCULATIONAHA.110.016337.
11. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Cefalu WT, Ryan DH, Hu G. Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab. 2013;98:3653-3662. doi: 10.1210/jc.2013-1757.
12. Zhao W, Katzmarzyk PT, Horswell R, Li W, Wang Y, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Blood pressure and heart failure risk among diabetic patients. Int J Cardiol. 2014;176:125-132. doi: 10.1016/j.ijcard.2014.06.051.
13. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care. 2013;36:3287-3296. doi: 10.2337/dc13-0189.
14. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
15. Kontopantelis E, Springate DA, Reeves D, Ashcroft DM, Rutter MK, Rutter M, Buchan I, Doran T. Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia. 2015;58:505-518. doi: 10.1007/s00125-014-3473-8.
16. Vamos EP, Harris M, Millett C, Pape UJ, Khunti K, Curcin V, Molokhia M, Majeed A. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study. BMJ. 2012;345:e5567.
17. Gelding S.V. Improving cardiovascular risk in type 2 diabetes: time to get personal. Eur Heart J.-Quality of Care and Clinical Outcomes. 2016;2:233-234. doi: 10.1093/ehjqcco/qcw033.
18. Lau IT. A clinical practice guideline to guide a system approach to diabetes care in Hong Kong. Diabetes Metab J. 2017;41:81-88. doi: 10.4093/dmj.2017.41.2.81.
19. Wong L, Lee M, Mak H, Wong P, Chung K, Wong K, Tam S, Li H, Chan T, Kung K. Accuracy and completeness of ICPC coding for chronic disease in general outpatient clinics. Hong Kong Practitioner. 2010;32:129-135.
20. Wong MC, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res. 2008;8:138. doi: 10.1186/1472-6963-8-138.
21. Fung V, Cheung N, Szeto K, Ngai L, Lau M, Kong JH. Hospital authority clinical vocabulary table-the past, the present, and the future. 2004 International Federation of Health Records Organization Congress Proceedings. 2004.
22. The Food and Health Bureau. HKSAR, The Department of Health HKSAR, The Hong Kong Hospital Authority. How to measure blood pressure using digital monitors. 2013. http://www.pco.gov.hk/english/resource/files/How-to-measure-blood-pressure-using-digital-mon.pdf. Accessed October 2, 2017.
23. Wan EY, Fung CS, Wong CK, Chin WY, Lam CL. Association of hemoglobin A1c levels with cardiovascular disease and mortality in Chinese patients with diabetes. J Am Coll Cardiol. 2016;67:456-458. doi: 10.1016/j.jacc.2015.11.020.
24. Sundström J, Sheikhi R, Ostgren CJ, Svennblad B, Bodegård J, Nilsson PM, Johansson G. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients. J Hypertens. 2013;31:1603-1610. doi: 10.1097/HJH.0b013e32836123aa.
25. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
27. Royston P. Multiple imputation of missing values. Stata Journal. 2004;4:227-241.
28. Rubin DB. Multiple imputation for nonresponse in surveys. New York, NY: John Wiley & Sons; 2004.
29. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990;131:373-375.
30. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-561.
31. Cushman WC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585. doi: 10.1056/NEJMoa1001286.
32. Hartaigh BÓ, Szymonifka J, Okin PM. Achieving target SBP for lowering the risk of major adverse cardiovascular events in persons with diabetes mellitus [published online ahead of print August 21, 2017]. J Hypertens. doi: 10.1097/HJH.0000000000001515.http://journals.lww.com/jhyper-tension/Abstract/publishahead/Achieving-target-SBP-for-lowering-the-risk-of.97638.aspx.
33. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352.
34. Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol. 2009;54:1827-1834. doi: 10.1016/j.jacc.2009.05.073.
35. Davies JE, Whinnett ZI, Francis DP, Manisty CH, Aguado-Sierra J, Willson K, Foale RA, Malik IS, Hughes AD, Parker KH, Mayet J. Evidence of a dominant backward-propagating "suction" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation. 2006;113:1768-1778. doi: 10.1161/CIRCULATIONAHA.105.603050.
36. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98:33-39. doi: 64682.
37. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10.1056/NEJMoa1511939.
38. Filipovský J, Seidlerová J, Kratochvíl Z, Karnosová P, Hronová M, Mayer O Jr. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25:228-234. doi: 10.3109/08037051.2015.1134086.
39. Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials. Hypertension. 2016;67:808-812. doi: 10.1161/HYPERTENSIONAHA.116.07257.
40. Schiffrin EL, Calhoun DA, Flack JM. SPRINT proves that lower is better for nondiabetic high-risk patients, but at a price. Am J Hypertens. 2016;29:2-4. doi: 10.1093/ajh/hpv190.
41. Nilsson PM, Kjeldsen SE. Blood pressure goals in type 2 diabetes-assessing the evidence. Lancet Diabetes Endocrinol. 2017;5:319-321. doi: 10.1016/S2213-8587(17)30035-9.
42. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991;265:3255-3264. doi: 10.1001/jama.1991.03460240051027.
43. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. doi: 10.1056/NEJMoa0801369.
44. Lacey B, Golledge J, Yeap BB, Lewington S, McCaul KA, Norman PE, Flicker L, Almeida O P, Hankey GJ. Systolic blood pressure and vascular disease in men aged 65 years and over: the HIMS (Health in Men Study). Hypertension. 2017;69:1053-1059. doi: 10.1161/HYPERTENSIONAHA.117.09150.
45. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-1886. doi: 10.1056/NEJM200006223422506.
46. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892. doi: 10.1056/NEJM200006223422507.
47. Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med. 2017;377:465-475. doi: 10.1056/NEJMra1614394.